Abstracts Archive - Page 2247 of 2607 - ACR Meeting Abstracts

Abstract Number: 2809 • 2013 ACR/ARHP Annual Meeting
Prevalence and Clinical Presentation Of Lyme Arthritis In a Large Cohort Of Patients With Recent-Onset Arthritis
Jeska K. De Vries-Bouwstra¹, Nathalie D. van Burgel², Tom Vreeswijk², Aloys C.M. Kroes², Tom W.J. Huizinga¹ and Annette H. M. van der Helm- van Mil¹, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: Lyme arthritis is a relatively uncommon form of arthritis that is relevant to identify because it requires specific therapy. The presents study aimed to…
Abstract Number: 2810 • 2013 ACR/ARHP Annual Meeting
Follow-Up Testing Of Interferon-Gamma Release Assays For The Diagnosis Of Hidden Tuberculosis Infection In Patients Receiving Tumor Necrosis Factor Alpha Antagonists
Chan-Nam Son¹, Tae-Hwan Kim², Il-Hoon Sung³, Jae-Bum Jun² and Dae-Hyun Yoo², ¹Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea, ²Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ³Orthopaedic surgery, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea
Background/Purpose: Anti-tumor necrosis factor alpha (Anti-TNFα) therapy is often used in patients with rheumatic diseases who do not respond to conventional treatment. Risk of tuberculosis…
Abstract Number: 2811 • 2013 ACR/ARHP Annual Meeting
Disease Characteristics and Treatment Patterns In US Veterans With Rheumatoid Arthritis and Concomitant Hepatitis C Infection
Ruchika Patel¹ and Joshua Baker², ¹Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA
Background/Purpose: The prevalence of concurrent rheumatoid arthritis (RA) and hepatitis C (HCV) is estimated at 0.02%, affecting around 40,000 Americans. To our knowledge, no existing…
Abstract Number: 2812 • 2013 ACR/ARHP Annual Meeting
A Rheumatology Objective Structured Clinical Examination Using Challenging Patient Scenarios Shows Trainee Use Of Medical Jargon Correlates Inversely With Patient Perceptions Of Professionalism
Jessica Berman¹, Juliet Aizer², Anne R. Bass², Anne Davidson³, Edward Dwyer⁴, Theodore R. Fields², Jane Kang⁵, Leslie Kerr⁶, Svetlana Krasnokutsky-Samuels⁷, Deana M. Lazaro⁸, Stephen A. Paget⁹, Julie S. Schwartzman-Morris¹⁰ and Michael H. Pillinger¹¹, ¹Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, ²Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, ³Autoimmunity and Musculoskeletal Diseases, Feinstein Institute for Medical Research, Manhasset, NY, ⁴Rheumatology, Columbia School of Medicine, New York, NY, ⁵Columbia School of Medicine, New York, NY, ⁶Mount Sinai School of Medicine, New York, NY, ⁷Rheumatology, NYU School of Medicine, New York, NY, ⁸Medical Service (111), Brooklyn VA, Brooklyn, NY, ⁹Division of Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, ¹⁰Department of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, ¹¹NYU School of Medicine, Division of Rheumatology, New York, NY
Background/Purpose: For 8 years, the New York City Rheumatology Objective Self Assessment Clinical Exam (NYC-ROSCE) has been used to assess trainee competencies such as patient…
Abstract Number: 2813 • 2013 ACR/ARHP Annual Meeting
Expert Panel Consensus On Content Of a Rheumatology Objective Structured Clinical Examination
Lisa G. Criscione-Schreiber¹, Marcy B. Bolster², Beth L. Jonas³, Richard Sloane⁴, Jeffrey Hawley⁵ and Kenneth S. O'Rourke⁶, ¹Rheumatology, Duke University Health System, Durham, NC, ²Medicine, Massachussetts General Hospital, Boston, MA, ³Thurston Arthritis Research Ct, University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁴Medicine/Geriatrics, Duke University Health System, Durham, NC, ⁵Duke University School of Nursing, Durham, NC, ⁶Section on Rheum & Immunology, Wake Forest School of Medicine, Winston-Salem, NC
Background/Purpose: Rheumatology objective structured clinical examinations (ROSCEs) are assessment tools to evaluate learner performance in simulated clinical experiences. ROSCEs allow standardization of learner assessment…
Abstract Number: 2814 • 2013 ACR/ARHP Annual Meeting
The Resident-Fellow Interaction: Limiting Barriers and Maximizing Learning
Eli Miloslavsky¹, Amy Sullivan², Jeremy Richards³, Jakob I. McSparron⁴, David Roberts³ and Alberto Puig⁵, ¹Division of Rheumatology, Massachusetts General Hopsital, Boston, MA, ²Medical Education, Beth Israel Deaconess Medical Center, Boston, MA, ³Pulmonary, Beth Israel Deaconess Medical Center, Boston, MA, ⁴Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, ⁵Medicine, Massachusetts General Hospital, Boston, MA
Background/Purpose: Subspecialty fellows may play an important role in Internal Medicine (IM) residents’ education and career specialty choice (Horn 2008). This may be particularly important…
Abstract Number: 2815 • 2013 ACR/ARHP Annual Meeting
Preliminary Entrustable Professional Activities in Muscloskeletal Ultrasound For Rheumatology Fellowship Training
Amy C. Cannella¹, Eugene Y. Kissin², Gurjit S. Kaeley³, Jay B. Higgs⁴, Kelly J. Caverzagie⁵ and Karina D. Torralba⁶, ¹Divison of Rheumatology, Omaha Veterans Affairs Hospital and University of Nebraska Medical Center, Omaha, NE, ²Boston University, Boston, MA, ³College of Medicine, University of Florida, Jacksonville, FL, ⁴Rheumatology, San Antonio Military Medical Center, JBSA - Fort Sam Houston, TX, ⁵Internal Medicine, University of Nebraska Medical Center, Omaha, NE, ⁶Loma Linda University, Loma Linda, CA
Preliminary Entrustable Professional Activities in Muscloskeletal Ultrasound for Rheumatology Fellowship Training Background/Purpose: As part of the Next Accreditation System (NAS), the Accreditation Council for Graduate…
Abstract Number: 2776 • 2013 ACR/ARHP Annual Meeting
Ankylosing Spondylitis Is Associated With An Increased Likelihood Of Cardiovascular Disease: A Nationwide Matched Cohort Study In Primary Care
Linda E. Dean¹, Gary J. Macfarlane¹, Alan G. MacDonald² and Gareth T. Jones¹, ¹Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ²Department of Rheumatology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom
Background/Purpose: Cardiovascular disease (CVD) risk is well established in rheumatoid arthritis but less so in ankylosing spondylitis (AS). Due to a similar inflammatory profile, AS…
Abstract Number: 2777 • 2013 ACR/ARHP Annual Meeting
Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: Part of a Common Spectrum Or Distinct Diseases? Analysis of a Longitudinal Prospective Cohort
Dinny Wallis¹, Nigil Haroon¹, Renise Ayearst², Adele Carty¹ and Robert D. Inman³, ¹Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³Toronto Western Hospital, University of Toronto, Toronto, ON, Canada
Ankylosing spondylitis and non-radiographic axial spondyloarthritis: part of a common spectrum or distinct diseases? Analysis of a longitudinal prospective cohort. Background/Purpose: Historically ankylosing spondylitis…
Abstract Number: 2778 • 2013 ACR/ARHP Annual Meeting
Mortality In United States Veterans With The HLA-B27 Gene
Jessica Walsh¹, Brian C. Sauer², Daniel O. Clegg¹, Grant W. Cannon³, Xi Zhou⁴ and Chiachen Teng⁴, ¹Division of Rheumatology, George E. Wahlen Veteran Affairs Medical Center, Salt Lake City, UT, ²Epdemiology, George E. Wahlen Veteran Affairs Medical Center, Salt Lake City, UT, ³Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, ⁴Epidemiology, George E. Wahlen Veteran Affairs Medical Center, Salt Lake City, UT
Background/Purpose : HLA-B27 (B27) is carried by in 6-8% of Americans and is strongly associated with spondyloarthritis (SpA). SpA has been associated with premature mortality.…
Abstract Number: 2779 • 2013 ACR/ARHP Annual Meeting
A Novel Evidence-Based Detection Of Undiagnosed Spondyloarthritis In Patients Presenting With Acute Anterior Uveitis: The DUET (Dublin Uveitis Evaluation Tool) Algorithm
Muhammad Haroon¹, Michael Anthony O'Rourke², Pathma Ramasamy², Conor Murphy² and Oliver FitzGerald¹, ¹Department of Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, ²Department of Ophthalmology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland
Background/Purpose: The prevalence of mostly undiagnosed underlying Spondyloarthropathy (SpA) is more than 60% among patients presenting with acute anterior uveitis (AAU). To date, there are…
Abstract Number: 2780 • 2013 ACR/ARHP Annual Meeting
Cumulative Exposure To Elevated Inflammatory Markers Is Associated With Increased Burden Of Atherosclerosis In Psoriatic Arthritis Patients: A Cohort Study
Lihi Eder¹, Arane Thavaneswaran², Vinod Chandran³, Richard J. Cook⁴ and Dafna D. Gladman³, ¹University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁴Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada
Background/Purpose: Cardiovascular morbidity is increased in patients with psoriatic arthritis (PsA). Traditional cardiovascular risk factors do not fully explain this excessive risk. It is unclear…
Abstract Number: 2781 • 2013 ACR/ARHP Annual Meeting
The Disease Characteristics and Predictors Of Minimal Disease Activity On TNF Blockers- Results From A Longitudainal Observational Cohort
Amir Haddad¹, Arane Thavaneswaran¹, Ioana Ruiz Arruza², Vinod Chandran², Richard J. Cook³ and Dafna D. Gladman², ¹Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada
Background/Purpose: A state of Minimal Disease Activity (MDA) has been defined and validated as a target for treatment in PsA. The purpose of the study…
Abstract Number: 2782 • 2013 ACR/ARHP Annual Meeting
Retreatment With Rituximab In The Rituximab In ANCA-Associated Vasculitis (RAVE) Trial
Eli Miloslavsky¹, Ulrich Specks², Peter A Merkel³, Philip Seo⁴, Robert F. Spiera⁵, Carol A. Langford⁶, Gary S. Hoffman⁷, Cees G.M. Kallenberg⁸, E. William St Clair⁹, Nadia Tchao¹⁰, Linna Ding¹¹, David Ikle¹², Brett Jepson¹², Paul Brunetta¹³ and John H. Stone¹⁴, ¹Division of Rheumatology, Massachusetts General Hopsital, Boston, MA, ²Mayo Clinic, Rochester, MN, ³Division of Rheumatology, University of Pennsylvania and VA Medical Center, Philadelphia, PA, ⁴Rheumatology Division, Johns Hopkins Vasculitis Center, Johns Hopkins University, Baltimore, MD, ⁵Rheumatology, Hospital for Special Surgery, New York, NY, ⁶Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH, ⁷Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH, ⁸Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, ⁹Medicine, Duke Unversity Medical Center, Durham, NC, ¹⁰Immune Tolerance Network, Bethesda, MD, ¹¹NIAID, Bethesda, MD, ¹²Rho, Chapel Hill, NC, ¹³Biotherapeutics, Genentech, So San Francisco, CA, ¹⁴Rheumatology, Massachusetts General Hospital, Boston, MA
Background/Purpose: Retrospective studies have demonstrated that repeat rituximab treatment may be effective in re-inducing remission in relapsing ANCA-associated vasculitis. We analyzed data from the Rituximab…
Abstract Number: 2783 • 2013 ACR/ARHP Annual Meeting
Rituximab Versus Azathioprine For Maintenance In Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis: Follow Up At 39 Months
Benjamin Terrier¹, Christian Pagnoux², Alexandre Karras³, Chahera Khouatra⁴, Olivier Aumaître⁵, Pascal Cohen⁶, Francois Maurier⁷, Olivier Decaux⁸, Hélène Desmurs-Clavel⁹, Pierre Gobert¹⁰, Thomas Quemeneur¹¹, Claire Blanchard-Delaunay¹², Pascal Godmer¹³, Xavier Puéchal¹⁴, Luc Mouthon¹⁵ and Loic Guillevin¹⁶, ¹Internal Medicine, Cochin University Hospital, Paris, France, ²Division of Rheumatology, University of Toronto, Toronto, ON, Canada, ³Nephrology, Hôpital Européen Georges Pompidou, APHP, Paris, France, ⁴CHU Lyon, Lyon, France, ⁵Division of internal Medicine, Centre Hospitalier Universitaire, Hôpital Gabriel Montpied, Clermont–Ferrand, Clermont–Ferrand, France, ⁶National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, ⁷HP Metz Belle Isle Hospital, Department of Internal Medicine, Metz, France, ⁸Department of Internal Medicine, Rennes University Hospital, Rennes, France, ⁹Internal Medicine, Hospices Civils de Lyon, Hôpital Louis Pradel, Lyon, France, ¹⁰Nephrology, Centre Hospitalier d'Avignon, Avignon, France, ¹¹Internal medicine, CHR de Valenciennes, Valenciennes, France, ¹²Internal Medicine, Hôpital de Niort, Niort, France, ¹³Department of Internal Medicine, Centre Hospitalier Bretagne Atlantique de Vannes, Vannes, France, ¹⁴National Referral Center for Rare Systemic Auto-immune Diseases, Hôpital Cochin, AP-HP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France, ¹⁵Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, Paris, France, ¹⁶Internal Medicine, Hôpital Cochin, University Paris Descartes, Paris, France
Rituximab Versus Azathioprine for Maintenance in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis: Follow up at 39 months.Background/Purpose: Rituximab was shown to be as effective as cyclophosphamide to…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].